Final Report of a Randomized Study of Decitabine Versus Conventional Care (CC) for Maintenance Therapy in Patients with Intermediate and High Risk Acute Myeloid Leukemia (AML) in First or Subsequent Complete Remission (CR)

Autor: Boumber, Yanis, Issa, Jean-Pierre, Jorgensen, Jeffrey L. *, Faderl, Stefan, Castoro, Ryan J *, Autry, Jane *, Garcia-Manero, Guillermo, Borthakur, Gautam, Jabbour, Elias, Estrov, Zeev, Cortes, Jorge E., Kantarjian, Hagop M., Ravandi, Farhad
Zdroj: In Blood 18 November 2011 118(21):1530-1530
Databáze: ScienceDirect